JPH0473406B2 - - Google Patents
Info
- Publication number
- JPH0473406B2 JPH0473406B2 JP5809485A JP5809485A JPH0473406B2 JP H0473406 B2 JPH0473406 B2 JP H0473406B2 JP 5809485 A JP5809485 A JP 5809485A JP 5809485 A JP5809485 A JP 5809485A JP H0473406 B2 JPH0473406 B2 JP H0473406B2
- Authority
- JP
- Japan
- Prior art keywords
- hair
- pge
- months
- present
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003676 hair preparation Substances 0.000 claims 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 claims 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 235000019441 ethanol Nutrition 0.000 description 8
- 230000003779 hair growth Effects 0.000 description 7
- 201000004384 Alopecia Diseases 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5809485A JPS61218510A (ja) | 1985-03-22 | 1985-03-22 | 毛髪用剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5809485A JPS61218510A (ja) | 1985-03-22 | 1985-03-22 | 毛髪用剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61218510A JPS61218510A (ja) | 1986-09-29 |
| JPH0473406B2 true JPH0473406B2 (https=) | 1992-11-20 |
Family
ID=13074359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5809485A Granted JPS61218510A (ja) | 1985-03-22 | 1985-03-22 | 毛髪用剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61218510A (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1021179B1 (en) * | 1997-02-04 | 2004-05-12 | Murray A. Johnstone | Method of enhancing hair growth |
| ATE281432T1 (de) | 1999-03-05 | 2004-11-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
| US6894175B1 (en) | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
| JP4162823B2 (ja) * | 2000-01-07 | 2008-10-08 | 花王株式会社 | 頭髪用化粧料 |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| WO2001072268A1 (en) * | 2000-03-31 | 2001-10-04 | Toray Industries, Inc. | Hair growth or hair formation controlling agents |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| FR2812190B1 (fr) * | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
| FR2812192B1 (fr) * | 2000-07-28 | 2003-01-31 | Oreal | Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils |
| FR2812191B1 (fr) * | 2000-07-28 | 2003-10-17 | Oreal | Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques |
| FR2812193B1 (fr) * | 2000-07-28 | 2003-10-24 | Oreal | Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques |
| US7351404B2 (en) | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
| US8758733B2 (en) | 2002-02-04 | 2014-06-24 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
| US9216183B2 (en) | 2002-02-04 | 2015-12-22 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
| TWI348386B (en) * | 2003-08-12 | 2011-09-11 | R Tech Ueno Ltd | Composition and method for promoting hair growth |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| DK2498783T3 (en) | 2009-11-09 | 2018-12-10 | Allergan Inc | COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH |
| US9149484B2 (en) | 2009-11-09 | 2015-10-06 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
| US8859616B2 (en) | 2011-01-21 | 2014-10-14 | Allergan, Inc. | Compounds and methods for enhancing hair growth |
-
1985
- 1985-03-22 JP JP5809485A patent/JPS61218510A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61218510A (ja) | 1986-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0473406B2 (https=) | ||
| CA2312729C (en) | Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease | |
| CA1203172A (en) | Propylene glycol diester solutions of pge-type compounds | |
| CA2043077C (en) | Prostaglandin analogues for use in medicine | |
| CA1226224A (en) | Dermatological preparation containing asa | |
| US4054736A (en) | Clathrate compounds of prostaglandins or their analogues with cyclodextrin | |
| KR100366200B1 (ko) | L-카르니틴염과이를함유한피부질환치료용화장품조성물및약제조성물 | |
| JP2001525803A (ja) | 勃起機能不全治療用の薬剤の調製のためのミソプロストール及び／又はミソプロストール酸の用途 | |
| JP3119430B2 (ja) | 水酸基ラジカル消去剤 | |
| ES2310013T3 (es) | Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina. | |
| CA1337928C (en) | Topically applied gold organic complex | |
| AU603005B2 (en) | Fervescence composition | |
| HU199293B (en) | Process for production of tepically applicable medical compositions suitable for treatment of peptical ulcus by mammates | |
| US4804530A (en) | Anaerobe-selective antibacterial compositions and methods | |
| US5028414A (en) | Anaerobe-selective antibacterial compositions and methods | |
| US4038417A (en) | Method for treatment of psoriasis | |
| KR100247441B1 (ko) | 트롬복산 레벨 억제용 경피투여 약제학적 아스피린 조성물 | |
| HU203470B (en) | Process for producing topical cosmetical pharamceutical compositions containing benzopirane-2-carboxylic acid derivatives of antiphlogistic activity | |
| JP2004538288A (ja) | プロスタグランジンアナログの局所的適用を包含する、発毛促進のための方法 | |
| JP2608135B2 (ja) | 糖尿病性神経障害治療剤 | |
| Shah et al. | Effects of single oral dose administration of a hydantoin prostaglandin analogue BW 245C in man | |
| JPH11286448A (ja) | ミノサイクリン含有組成物 | |
| DE1810845C3 (de) | FlOssiges, pastöses oder festes zahnschmelzschonendes desinfizierendes und kariesverhütendes Zahnpflegemittel | |
| US6897239B1 (en) | Use of misoprostol and/or metabolites of misoprostol for treating sexual dysfunction in women | |
| Nebbia et al. | Pathogenesis of sodium selenite and dimethylselenide acute toxicosis in pigs: cardiovascular changes |